Naomi J Clout1, Erhard Hohenester. 1. Department of Biological Sciences, Imperial College London, South Kensington Campus, London, United Kingdom. n.clout@imperial.ac.uk
Abstract
PURPOSE: A progressive alteration of the cornea resulting in loss of transparency occurs in a set of hereditary diseases known as corneal dystrophies. A number of these dystrophies have been linked to mutations in the 5q31-linked gene product beta(ig)-h3 (TGFBIP, kerato-epithelin, MP78/70, RGD-CAP) although the mechanism by which the mutations cause disease remains unknown. Here we investigate the structural basis for the different corneal dystrophies caused by mutations of the beta(ig)-h3 protein. The integrin binding properties of beta(ig)-h3, described in several recent studies, have been analysed with respect to the beta(ig)-h3 structure. METHODS: The recently determined structure of a FAS1 domain pair from fasciclin I, an insect cell adhesion molecule and beta(ig)-h3 homologue, was used to generate a homology model of the beta(ig)-h3 FAS1 domain 4. RESULTS: The structural analysis of FAS1 domain 4 of beta(ig)-h3 predicts that the common mutations at positions 124 and 555 do not substantially alter the beta(ig)-h3 structure. In contrast, the rare missense mutations appear incompatible with the FAS1 fold. A number of residues implicated in integrin binding by previous mutagenesis are mostly buried and appear to have important structural roles. CONCLUSIONS: The common mutations of beta(ig)-h3 at positions 124 and 555 are likely to affect protein-protein interactions directly, whereas the rare mutations are likely to cause misfolding of the protein within the cell. Previously identified integrin binding residues are unlikely to be directly involved in receptor binding.
PURPOSE: A progressive alteration of the cornea resulting in loss of transparency occurs in a set of hereditary diseases known as corneal dystrophies. A number of these dystrophies have been linked to mutations in the 5q31-linked gene product beta(ig)-h3 (TGFBIP, kerato-epithelin, MP78/70, RGD-CAP) although the mechanism by which the mutations cause disease remains unknown. Here we investigate the structural basis for the different corneal dystrophies caused by mutations of the beta(ig)-h3 protein. The integrin binding properties of beta(ig)-h3, described in several recent studies, have been analysed with respect to the beta(ig)-h3 structure. METHODS: The recently determined structure of a FAS1 domain pair from fasciclin I, an insect cell adhesion molecule and beta(ig)-h3 homologue, was used to generate a homology model of the beta(ig)-h3FAS1 domain 4. RESULTS: The structural analysis of FAS1 domain 4 of beta(ig)-h3 predicts that the common mutations at positions 124 and 555 do not substantially alter the beta(ig)-h3 structure. In contrast, the rare missense mutations appear incompatible with the FAS1 fold. A number of residues implicated in integrin binding by previous mutagenesis are mostly buried and appear to have important structural roles. CONCLUSIONS: The common mutations of beta(ig)-h3 at positions 124 and 555 are likely to affect protein-protein interactions directly, whereas the rare mutations are likely to cause misfolding of the protein within the cell. Previously identified integrin binding residues are unlikely to be directly involved in receptor binding.
Authors: D Suesskind; C Auw-Haedrich; D F Schorderet; F L Munier; K U Loeffler Journal: Graefes Arch Clin Exp Ophthalmol Date: 2005-12-06 Impact factor: 3.117
Authors: Anthony J Aldave; Vivek S Yellore; Baris Sonmez; Nirit Bourla; Andrew K Salem; M Ali Khan; Sylvia A Rayner; Ben J Glasgow Journal: Arch Ophthalmol Date: 2008-03